Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Gilead Sciences
Allogene Therapeutics
Jonsson Comprehensive Cancer Center
Sanofi
Affimed GmbH
Adicet Therapeutics
Thomas Jefferson University
CARGO Therapeutics
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Hoffmann-La Roche
M.D. Anderson Cancer Center
Celgene
Fred Hutchinson Cancer Center
Gilead Sciences
Fate Therapeutics
Fate Therapeutics
Bristol-Myers Squibb
The Christie NHS Foundation Trust
Medical College of Wisconsin
Fred Hutchinson Cancer Center
University Hospital Tuebingen
Indiana University
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
Baylor College of Medicine
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Columbia University
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Weill Medical College of Cornell University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indiana University
Massachusetts General Hospital
Hoffmann-La Roche
Pfizer
University of Alabama at Birmingham
St. Jude Children's Research Hospital
Massachusetts General Hospital
Hoosier Cancer Research Network
Hoffmann-La Roche
German CLL Study Group
Dana-Farber Cancer Institute